Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy

被引：1
|
作者：
Bonfanti, P [1 ]
Landonio, S
Ricci, E
Martinelli, C
Fortuna, P
Faggion, I
Quirino, T
机构：
[1] Luigi Sacco Hosp, Dept Infect Dis, Milan, Italy
[2] Ist Ric Farmacol Mario Negri, Milan, Italy
[3] Careggi Hosp, Dept Infect Dis, Florence, Italy
[4] S Gerardo Hosp, Dept Infect Dis, Monza, Italy
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2001年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：316 / 318
页数：3
相关论文
共 50 条
  • [1] Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Jabs, DA
    Holbrook, JT
    Van Natta, ML
    Clark, R
    Jacobson, MA
    Kempen, JH
    Murphy, RL
    [J]. OPHTHALMOLOGY, 2005, 112 (05) : 771 - 779
  • [2] Hepatotoxicity after introduction of highly active antiretroviral therapy
    Rodríguez-Rosado, R
    García-Samaniego, J
    Soriano, V
    [J]. AIDS, 1998, 12 (10) : 1256 - 1256
  • [3] Hepatotoxicity associated with highly active antiretroviral therapy (HAART) in HIV/AIDS patients
    Dragovic, G
    Jevtovic, D
    [J]. DRUG SAFETY, 2005, 28 (10) : 951 - 952
  • [4] Cerebrovascular disease in highly active antiretroviral therapy-treated individuals: Incidence and risk factors
    d'Arminio Monforte, Antonella
    Bongiovanni, Marco
    [J]. JOURNAL OF NEUROVIROLOGY, 2005, 11 : 34 - 37
  • [5] Influence of past hepatitis B upon risk of highly active antiretroviral therapy induced hepatotoxicity
    Hoffman-Terry, M
    Smith, A
    O'Donnell, E
    Wasser, T
    [J]. XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE, 2002, : 123 - 126
  • [6] Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy -: Survival and risk factors of death
    Wyen, C
    Hoffmann, C
    Schmeissner, N
    Wöhrmann, A
    Qurishi, N
    Rockstroh, A
    Esser, S
    Rieke, A
    Ross, B
    Lorenzen, T
    Schmitz, K
    Stenzel, W
    Salzberger, B
    Fätkenheuer, G
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (02) : 1263 - 1268
  • [7] Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy
    Berenguer, J
    Miralles, P
    Arrizabalaga, J
    Ribera, E
    Dronda, F
    Baraia-Etxaburu, J
    Domingo, P
    Márquez, M
    Rodriguez-Arrondo, FJ
    Laguna, F
    Rubio, R
    Rodrigo, JL
    Mallolas, J
    de Miguel, V
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 36 (08) : 1047 - 1052
  • [8] Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in Africa: a reply
    Lawn, Stephen D.
    Badri, Motasim
    Wood, Robin
    [J]. AIDS, 2006, 20 (10) : 1463 - 1465
  • [9] Hepatotoxicity after introduction of highly active antiretroviral therapy (HAART) in HIV infected patients.
    Rodriguez-Rosado, R
    Garcia-Samaniego, J
    Perez-Olmeda, M
    Soriano, V
    Munoz, F
    Gonzalez-Lahoz, J
    [J]. HEPATOLOGY, 1998, 28 (04) : 434A - 434A
  • [10] Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
    Bernasconi, E
    Uhr, M
    Magenta, L
    Ranno, A
    Telenti, A
    [J]. AIDS, 2001, 15 (08) : 1081 - 1082
12345